🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The purpose of this study is to assess immune response and safety of variou...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-03
Trial ID
NCT05084508
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-25
Trial ID
NCT02184572
Treatments Being Tested
The purpose of this study is to support licensure of GSK Biologicals' MMR v...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-06-21
Trial ID
NCT01621802
The purpose of this study is to determine whether vYF (investigational vacc...
Status
Recruiting
Location
Investigational Site Number : 3400001
Start Date
2025-07-11
Trial ID
NCT07103148
This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-22
Trial ID
NCT00289783
The purpose of this study is to test the safety of a measles, mumps, and ru...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00109278
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2024-01-15
Trial ID
NCT06213506
To evaluate the Immunogenicity and Safety of Shanghai Institute of Biologic...
Status
Completed
Location
Victoria Biomedical Research Institute(VIBRI)
Start Date
2024-06-28
Trial ID
NCT06399003
Treatments Being Tested